Boryung Pharmaceutical 'Bringjer Molecular Fermented Red Ginseng'

Rapid Absorption of Red Ginseng Nutrients... Also Added Postbiotics View original image

[Asia Economy Reporter Seo So-jung] Recently, as consumers increasingly consider health and immune system enhancement due to COVID-19, various types of Red Ginseng have gained attention. However, according to various studies, when consuming Red Ginseng, the microorganisms in the body are not properly activated, resulting in the core high-molecular components of Red Ginseng not being absorbed or only partially absorbed.


Boryung Consumer Healthcare has launched 'Bringer Molecular Fermented Red Ginseng,' which allows for fast and deep absorption of Red Ginseng nutrients. This product effectively enables the absorption of 'ginsenosides (a general term for saponins in ginseng)' in the body by applying the patented 'Compound K' and 'Pre- & Probiotics' formula.


Compound K is the final metabolite produced by breaking down ginsenosides, which are difficult to absorb in their high-molecular form, into low-molecular forms through intestinal microorganisms. Generally, molecules with a molecular weight below 1000 Daltons are classified as low-molecular. Bringer Molecular Fermented Red Ginseng features a standardized Compound K of 622.8 Daltons, produced through a patented manufacturing process using lactic acid bacteria enzymes, which enhances absorption in the body.



Additionally, prebiotics and postbiotics, which serve as food for lactic acid bacteria, are added to promote a healthy gut microbiome and further increase the absorption rate of Red Ginseng. The product uses a gumbo formulation made from 'carrageenan' derived from red algae and 'pectin' derived from citrus and apple juice, providing a unique chewy yet soft texture. It can be conveniently consumed once a day with one sachet.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing